PYRIDOBENZOXAZEPINE AND PYRIDOBENZOTHIAZEPINE DERIVATIVES AS POTENTIAL CENTRAL-NERVOUS-SYSTEM AGENTS - SYNTHESIS AND NEUROCHEMICAL STUDY

被引:99
作者
LIEGEOIS, JFF
ROGISTER, FA
BRUHWYLER, J
DAMAS, J
NGUYEN, TP
INAREJOS, MO
CHLEIDE, EMG
MERCIER, MGA
DELARGE, JE
机构
[1] UNIV NAMUR,DEPT EXPTL PSYCHOL,B-5000 NAMUR,BELGIUM
[2] UNIV LIEGE,PHYSIOL LAB,B-4020 LIEGE,BELGIUM
关键词
D O I
10.1021/jm00030a011
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In order to characterize the pharmacological profile of-the different chemical classes of pyridobenzazepine derivatives, a series of N-methylpiperazinopyrido[1,4]- and -[1,5]- benzoxa- and benzothiazepine derivatives were prepared. The affinities-for D-2, D-1, 5-HT2, and cholinergic (M)receptors were measured. In comparison to dibenzazepine reference compounds, a strong decrease of the affinities was observed, less pronounced, however, for the substituted analogues. Oxazepine and thiazepine analogues like clozapine (except 8-chloro-6-(4-methylpiperazin-1-yl)pyrido[2,3-b] [1,4]-benzoxazepine (9) and 8-chloro-6-(4-methylpiperazin-1-yl)pyrido[2,3-b][1,4]-benzothiazepine (11)) were found to be inactive against apomorphine stereotypies. In the open-field test in rats, different molecules showed-a high disinhibitory activity as observed with anxiolytic drugs. Moreover, 8-chloro-5-(4-methylpiperazin-1-yl)pyrido [2,3-b] [1,5]benzoxazepine (14) presented a clozapine-like profile that was confirmed in the behavioral model in dogs and showed most of the behavioral characteristics described for antipsychotic drugs. Its neurochemical profile, in particular the 5-HT2/D-2 ratio was also compatible with atypical antipsychotic activity.
引用
收藏
页码:519 / 525
页数:7
相关论文
共 66 条
  • [1] SELECTIVE, CENTRALLY ACTING SEROTONIN 5-HT2 ANTAGONISTS .2. SUBSTITUTED 3-(4-FLUOROPHENYL)-1H-INDOLES
    ANDERSEN, K
    PERREGAARD, J
    ARNT, J
    NIELSEN, JB
    BEGTRUP, M
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (26) : 4823 - 4831
  • [2] BALDESSARINI RJ, 1991, NEW ENGL J MED, V324, P746
  • [3] BALDESSARINI RJ, 1990, PHARMACOL BASIS THER, P383
  • [4] NEUROTROPIC AND PSYCHOTROPIC AGENTS .65. 8-CHLORO AND 8-ISOPROPYL-6-PIPERAZINOBENZO[B]PYRIDO[3,2-F] THIEPIN
    BARTL, V
    METYSOVA, J
    PROTIVA, M
    [J]. COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 1973, 38 (09) : 2778 - 2787
  • [5] NEUROTROPIC AND PSYCHOTROPIC AGENTS .61. DERIVATIVES OF 6-PIPERAZINOBENZO[B]PYRIDO[3,2-F]THIEPIN
    BARTL, V
    METYSOVA, J
    PROTIVA, M
    [J]. COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 1973, 38 (06) : 1693 - 1699
  • [6] CHARACTERIZATION OF THE BINDING OF H-3-SCH 23390, A SELECTIVE D-1 RECEPTOR ANTAGONIST LIGAND, IN RAT STRIATUM
    BILLARD, W
    RUPERTO, V
    CROSBY, G
    IORIO, LC
    BARNETT, A
    [J]. LIFE SCIENCES, 1984, 35 (18) : 1885 - 1893
  • [7] COMPARATIVE-STUDY OF THE BEHAVIORAL, NEUROPHYSIOLOGICAL, AND MOTOR EFFECTS OF PSYCHOTROPIC-DRUGS IN THE DOG
    BRUHWYLER, J
    CHLEIDE, E
    [J]. BIOLOGICAL PSYCHIATRY, 1990, 27 (11) : 1264 - 1278
  • [8] ANXIOLYTIC POTENTIAL OF SULPIRIDE, CLOZAPINE AND DERIVATIVES IN THE OPEN-FIELD TEST
    BRUHWYLER, J
    CHLEIDE, E
    LIEGEOIS, JF
    DELARGE, J
    MERCIER, M
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 36 (01) : 57 - 61
  • [9] DIFFERENTIATION OF HALOPERIDOL AND CLOZAPINE USING A COMPLEX OPERANT SCHEDULE IN THE DOG
    BRUHWYLER, J
    CHLEIDE, E
    HOUBEAU, G
    WAEGENEER, N
    MERCIER, M
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, 44 (01) : 181 - 189
  • [10] BRUHWYLER J, 1992, BEHAV PHARMACOL, V3, P567